Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Long-Term Deferred Tax (2022)

Gossamer Bio (GOSS) has 1 years of Long-Term Deferred Tax data on record, last reported at $205.9 million in Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax changed N/A year-over-year to $205.9 million; the TTM value through Dec 2022 reached $205.9 million, changed N/A, while the annual FY2022 figure was $205.9 million, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $205.9 million in Q4 2022 per GOSS's latest filing.
  • Across five years, Long-Term Deferred Tax topped out at $205.9 million in Q4 2022 and bottomed at $205.9 million in Q4 2022.